Jay Patel, MD
Orthopaedic Surgery · Orange, CANPI 1982900890
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $214,859 of the $245,312 with a category attached, or 87.6%. 23 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 53.3% of the total. Reporting peaked in 2021 at $100,191 and has fallen 99.8% since, to $214 in 2025. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $1095.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$131K
- Zimmer Biomet$106K
- UOC USA Inc$5K
- Exactech, Inc.$2K
- Medical Device Business Services, Inc.$303
- Edwards Lifesciences$184
- plus $1K from 17 others
Across 7 payments — averaging $246.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$972
- Zimmer Biomet$750
What the payments were for
- Consulting fees$214,85988%
- Travel & lodging$27,05511%
- Food & beverage$3,3981%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 63 | $130,831 |
| Zimmer Biomet | 108 | $106,336 |
| UOC USA Inc | 12 | $4,981 |
| Exactech, Inc. | 3 | $1,589 |
| Medical Device Business Services, Inc. | 12 | $303 |
| Edwards Lifesciences | 1 | $184 |
| Smith+Nephew | 2 | $173 |
| Stryker | 1 | $150 |
| Pacira Pharmaceuticals Incorporated | 1 | $126 |
| Pacira Therapeutics, Inc. | 4 | $116 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $88 |
| Bioventus LLC | 3 | $58 |
| SPR Therapeutics, Inc | 1 | $56 |
| Vertex | 2 | $53 |
| VYNE Pharmaceuticals Inc. | 1 | $53 |
| Ortho Development Corporation | 1 | $51 |
| Treace Medical Concepts, Inc. | 1 | $38 |
| Johnson & Johnson(2 entities) | 2 | $32 |
| Molnlycke Health Care US, LLC | 1 | $30 |
| Avanos Medical | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Zimvie Inc. | 1 | $15 |
| Encore Medical, LP | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ATTUNE$119,395
- Persona Revision$27,875
- Taperloc$27,872
- Avenir$27,203
- G7$19,963
- HP PARTIAL$10,525
- Persona$7,347
- Knees Product Portfolio$6,500
- Arcos$5,060
- Fuzion$3,500
- Trabecular Metal (TM)$3,000
- UM3$2,745
- Persona IQ$2,500
- U-Star II$1,830
- ALTEON$1,496
- MyMobility$1,000
- Oxford-Knees$500
- Knees-MyMobility$500
- Patient Care$250
- SAPIEN 3 Ultra RESILIA$184
How this compares
$245,312 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 242 | $2,804 |
| Oxycodone Hcl | 144 | $864 |
| Meloxicam | 224 | $604 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 47 | $359 |
| Tramadol Hcl | 100 | $303 |
| Methocarbamol | 63 | $267 |
| Amoxicillin | 125 | $247 |
| Ondansetron Hcl | 23 | $208 |
| Clindamycin Hcl | 31 | $126 |
| Baclofen | 21 | $107 |
| Gabapentin | 11 | $40 |
| Zolpidem Tartrate | 14 | $12 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Orange
- Robert GorabOrange$13.6M
- Steven BarnettOrange$797K
- Jonah Hebert DaviesOrange$653K
- Bradford HackArcadia$18.3M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Nirav AminPlacentia$5.6M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.